Ridgeline Discovery Revenue and Competitors

Basel, SWI

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ridgeline Discovery's estimated annual revenue is currently $14.7M per year.(i)
  • Ridgeline Discovery's estimated revenue per employee is $155,000

Employee Data

  • Ridgeline Discovery has 95 Employees.(i)
  • Ridgeline Discovery grew their employee count by 42% last year.

Ridgeline Discovery's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.9M9616%N/AN/A
#2
$75.3M48621%N/AN/A
#3
$10.9M706%N/AN/A
#4
$17.4M11237%N/AN/A
#5
$14.7M9542%N/AN/A
#6
$10.9M70-10%N/AN/A
Add Company

What Is Ridgeline Discovery?

Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >50 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.

keywords:N/A

N/A

Total Funding

95

Number of Employees

$14.7M

Revenue (est)

42%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29.9M965%N/A
#2
$53.9M1027%N/A
#3
$23.2M10221%N/A
#4
$15.5M107-4%N/A
#5
$11M108-7%N/A